Vitreretinal surgery with and without oral anticoagulants: surgical complications, visual results and perioperative thromboembolic events.

AVARRBIOMED-FUNDACION MIGUEL SERVET0 个研究点目标入组 96 人开始时间: 2018年6月20日最近更新: 2019年1月7日

适应症

试验速览

暂无简介。

•1. Adults (over 18 years) of both sexes.
•2. Clinical indication for vitrectomy alone or associated with facoemulsification or scleral buckling.
•3. Under treatment with any of the following oral anticoagulants: acenocumarol, dabigatran, rivaroxaban, apixaban or edoxaban.
•4. Able to give informed consent for vitreoretinal surgery and to participate in the trial.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 50
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 46

•1. Patients unable to be operated under retrobulbar anesthesia.
•2. Patients on antiplatelet therapy except if the antiaggregation is with acetylsalicylic acid.
•3. Patients who have recently started oral anticoagulation (less than 1 month before screening).
•4. Any medical, psychological, psychiatric, geographic or social situation that could interfere with the participation of the patient in the trial or with the follow-up and adherence with the protocol and the evaluation of the results of the present trial.

发起方

AVARRBIOMED-FUNDACION MIGUEL SERVET